Financhill
Back

Novo Nordisk A/S Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison

Sell
33

NVO
Novo Nordisk A/S

Last Price:
$51.57
Seasonality Move:
3.96%
Sell
2

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
$2.30
Seasonality Move:
-21.69%
Sell
33
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $51.47. The Score for NVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals Plc [BDRX] share price is $2.32. The Score for BDRX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $51.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals Plc's stock price today?

  • The Biodexa Pharmaceuticals Plc share price today is $2.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.57 Buy
Relative Strength Index (14 RSI): 57.68 Buy
Chaikin Money Flow: -10347113 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.88 - 50.6) Buy
Bollinger Bands (100): (48.47 - 56.99) Sell

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.68 Sell
Relative Strength Index (14 RSI): 38.66 Sell
Chaikin Money Flow: -283584 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.29 - 6.01) Sell
Bollinger Bands (100): (4.63 - 7.43) Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.95 Buy
20-day SMA: 49.04 Buy
50-day SMA: 49.45 Buy
200-day SMA: 60.18 Sell
8-day EMA: 50.65 Buy
20-day EMA: 49.64 Buy
50-day EMA: 50.41 Buy
200-day EMA: 62.52 Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.86 Sell
20-day SMA: 4.77 Sell
50-day SMA: 5.39 Sell
200-day SMA: 9.17 Sell
8-day EMA: 3.49 Sell
20-day EMA: 4.36 Sell
50-day EMA: 5.22 Sell
200-day EMA: 181.41 Sell

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.18 per share.

Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.40 per share.

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biodexa Pharmaceuticals Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):